Study of Riluzole for Patients with Spinocerebellar Ataxia Type 7
- Substances:Riluzole
Italy- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Riluzole
- Sponsor:Universita Degli Studi Di Roma La Sapienza
Rare diseases
Investigational molecules
Locations

Via Di Grottarossa 1035-1039, 00189 Rome, Italy
Research activity centers on non-muscle invasive bladder cancer, with attention to transurethral resection of bladder tumour care, photodynamic diagnosis, and refinement of surgical decision-making in patients considered for repeat resection.
The clinical focus includes bladder-sparing treatment pathways, recurrence monitoring, and personalized urologic cancer management.
Universita Degli Studi Di Roma La Sapienza runs clinical trials in conditions such as Bladder transitional cell carcinoma, Bladder transitional cell carcinoma recurrent, Bladder transitional cell carcinoma stage 0, Bladder transitional cell carcinoma stage I, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Italy
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.